Close
4

Seqens Seqens

X

Company profile for Perception Neuroscience

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
Perception Neuroscience’s lead development product is the NMDA antagonist arketamine (PCN-101), a single isomer of ketamine. Arketamine belongs to a new generation of glutamate receptor modulators with the suggested potential for rapid acting antidepressant (RAAD) activity. Most of the currently FDA-approved antidepressant therapies often take weeks to achieve maximal effectiveness. Perception Neuroscience was founded on the...
Perception Neuroscience’s lead development product is the NMDA antagonist arketamine (PCN-101), a single isomer of ketamine. Arketamine belongs to a new generation of glutamate receptor modulators with the suggested potential for rapid acting antidepressant (RAAD) activity. Most of the currently FDA-approved antidepressant therapies often take weeks to achieve maximal effectiveness. Perception Neuroscience was founded on the basis of evidence from animal models of depression as well as safety reports from academic studies in healthy volunteers.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Perception Neuroscience
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
180 Varick Street, Suite 637 New York, NY 10014
Telephone
Telephone
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY